methotrexate has been researched along with Scleroderma, Limited in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespo, J; Moreira, S; Santos, L | 1 |
| Tran, MMA | 1 |
| Ban, YS; Choi, WS; Kim, JH; Park, SY | 1 |
| Quisumbing, JP; Yu, MG | 1 |
4 other study(ies) available for methotrexate and Scleroderma, Limited
| Article | Year |
|---|---|
Lymphedema secondary to limited cutaneous systemic sclerosis.
Topics: Female; Humans; Lymphedema; Lymphoscintigraphy; Methotrexate; Microscopic Angioscopy; Middle Aged; Prednisolone; Raynaud Disease; Scleroderma, Limited; Treatment Outcome | 2018 |
An indurated, longitudinal plaque on the arm of a seven-year-old girl.
Topics: Child; Dermatologic Agents; Diagnosis, Differential; Exanthema; Female; Humans; Methotrexate; Scleroderma, Limited | 2018 |
Acro-osteolysis and calcinosis in patient with scleroderma: A case report.
Topics: Acro-Osteolysis; Antirheumatic Agents; Calcinosis; Female; Finger Joint; Finger Phalanges; Glucocorticoids; Humans; Methotrexate; Middle Aged; Orthopedic Procedures; Radiography; Scleroderma, Limited; Treatment Outcome; Wrist Joint | 2017 |
Limited cutaneous systemic sclerosis arising in a patient with Graves' disease.
Topics: Adult; Antithyroid Agents; Facial Dermatoses; Female; Graves Disease; Hormone Replacement Therapy; Humans; Hypothyroidism; Immunosuppressive Agents; Iodine Radioisotopes; Methimazole; Methotrexate; Neck; Scleroderma, Limited; Thyroxine | 2017 |